ID   LG2 DO-KO-2
AC   CVCL_C5VK
SY   DO-KO-2
DR   PRIDE; PXD010301
DR   Wikidata; Q116049682
RX   PubMed=30573663;
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:4937; HLA-DOB.
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Proteomics; HLA class II peptidome.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C5UW ! LG2
SX   Male
CA   Transformed cell line
DT   Created: 15-12-22; Last updated: 10-04-25; Version: 5
//
RX   PubMed=30573663; DOI=10.1074/mcp.RA118.000956; PMCID=PMC6398211;
RA   Nanaware P.P., Jurewicz M.M., Leszyk J.D., Shaffer S.A., Stern L.J.;
RT   "HLA-DO modulates the diversity of the MHC-II self-peptidome.";
RL   Mol. Cell. Proteomics 18:490-503(2019).
//